Advertisement
Screener

LIFEVANTAGE CORP (LFVN) Increase (Decrease) in Income Taxes Receivable

2.8 / 5 stars · 68/120 Roast Me

LIFEVANTAGE CORP Increase (Decrease) in Income Taxes Receivable

LIFEVANTAGE CORP (LFVN) reported Increase (Decrease) in Income Taxes Receivable of $751.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2026-08-27

  • LIFEVANTAGE CORP increase (decrease) in income taxes receivable for the quarter ending 2026-06-30 was -$815.00K, a 228.35% decline year-over-year.
  • LIFEVANTAGE CORP increase (decrease) in income taxes receivable for the quarter ending 2026-03-31 was -$525.00K.
  • LIFEVANTAGE CORP increase (decrease) in income taxes receivable for the quarter ending 2025-12-31 was -$2.57M.
  • LIFEVANTAGE CORP increase (decrease) in income taxes receivable for the quarter ending 2025-09-30 was $4.66M, a 713.79% increase year-over-year.
  • LIFEVANTAGE CORP increase (decrease) in income taxes receivable for fiscal 2026 was $751.00K, a 133.23% increase from fiscal 2025.
  • LIFEVANTAGE CORP increase (decrease) in income taxes receivable for fiscal 2025 was $322.00K, a 353.52% increase from fiscal 2024.
  • LIFEVANTAGE CORP increase (decrease) in income taxes receivable for fiscal 2024 was $71.00K.
  • LIFEVANTAGE CORP increase (decrease) in income taxes receivable for fiscal 2023 was -$1.51M, a 311.78% decline from fiscal 2022.
Period endIncrease (Decrease) in Income Taxes Receivable 3 monthIncrease (Decrease) in Income Taxes Receivable 6 monthIncrease (Decrease) in Income Taxes Receivable 9 monthIncrease (Decrease) in Income Taxes Receivable 12 month
2026-06-30-$815.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27
-$1.34M
derived: sum of 2 quarters · filed 2026-08-27
-$3.91M
derived: sum of 3 quarters · filed 2026-08-27
$751.00K
10-K · filed 2026-08-27
2026-03-31-$525.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06
-$3.10M
derived: sum of 2 quarters · filed 2026-05-06
$1.57M
10-Q · filed 2026-05-06
$2.20M
derived: sum of 4 quarters · filed 2026-08-27
2025-12-31-$2.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04
$2.09M
10-Q · filed 2026-02-04
$2.73M
derived: sum of 3 quarters · filed 2026-08-27
$2.73M
derived: sum of 4 quarters · filed 2026-08-27
2025-09-30$4.66M
10-Q · filed 2025-11-04
$5.30M
derived: sum of 2 quarters · filed 2026-08-27
$5.30M
derived: sum of 3 quarters · filed 2026-08-27
$4.41M
derived: sum of 4 quarters · filed 2026-08-27
2025-06-30$635.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27
$635.00K
derived: sum of 2 quarters · filed 2026-08-27
-$251.00K
derived: sum of 3 quarters · filed 2026-08-27
$322.00K
10-K · filed 2026-08-27
2025-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06
-$886.00K
derived: sum of 2 quarters · filed 2026-05-06
-$313.00K
10-Q · filed 2026-05-06
-$360.00K
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31-$886.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04
-$313.00K
10-Q · filed 2026-02-04
-$360.00K
derived: sum of 3 quarters · filed 2026-02-04
-$235.00K
derived: sum of 4 quarters · filed 2026-02-04
2024-09-30$573.00K
10-Q · filed 2025-11-04
$526.00K
derived: sum of 2 quarters · filed 2025-11-04
$651.00K
derived: sum of 3 quarters · filed 2025-11-04
$736.00K
derived: sum of 4 quarters · filed 2025-11-04
2024-06-30-$47.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-04
$78.00K
derived: sum of 2 quarters · filed 2025-09-04
$163.00K
derived: sum of 3 quarters · filed 2025-09-04
$71.00K
10-K · filed 2025-09-04
2024-03-31$125.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06
$210.00K
derived: sum of 2 quarters · filed 2025-05-06
$118.00K
10-Q · filed 2025-05-06
-$302.00K
derived: sum of 4 quarters · filed 2025-05-06
2023-12-31$85.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-05
-$7.00K
10-Q · filed 2025-02-05
-$427.00K
derived: sum of 3 quarters · filed 2025-02-05
-$656.00K
derived: sum of 4 quarters · filed 2025-02-05
2023-09-30-$92.00K
10-Q · filed 2024-10-29
-$512.00K
derived: sum of 2 quarters · filed 2024-10-29
-$741.00K
derived: sum of 3 quarters · filed 2024-10-29
$149.00K
derived: sum of 4 quarters · filed 2024-10-29
2023-06-30-$420.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28
-$649.00K
derived: sum of 2 quarters · filed 2024-08-28
$241.00K
derived: sum of 3 quarters · filed 2024-08-28
-$1.51M
10-K · filed 2024-08-28
2023-03-31-$229.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-02
$661.00K
derived: sum of 2 quarters · filed 2024-05-02
-$1.09M
10-Q · filed 2024-05-02
-$143.00K
derived: sum of 4 quarters · filed 2024-05-02
2022-12-31$890.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-30
-$861.00K
10-Q · filed 2024-01-30
$86.00K
derived: sum of 3 quarters · filed 2024-01-30
-$7.00K
derived: sum of 4 quarters · filed 2024-01-30
2022-09-30-$1.75M
10-Q · filed 2023-11-09
-$804.00K
derived: sum of 2 quarters · filed 2023-11-09
-$897.00K
derived: sum of 3 quarters · filed 2023-11-09
$1.00K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$947.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-28
$854.00K
derived: sum of 2 quarters · filed 2023-08-28
$1.75M
derived: sum of 3 quarters · filed 2023-08-28
$713.00K
10-K · filed 2023-08-28
2022-03-31-$93.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-04
$805.00K
derived: sum of 2 quarters · filed 2023-05-04
-$234.00K
10-Q · filed 2023-05-04
$40.00K
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31$898.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-02
-$141.00K
10-Q · filed 2023-02-02
$133.00K
derived: sum of 3 quarters · filed 2023-02-02
$361.00K
derived: sum of 4 quarters · filed 2023-02-02
2021-09-30-$1.04M
10-Q · filed 2022-11-02
-$765.00K
derived: sum of 2 quarters · filed 2022-11-02
-$537.00K
derived: sum of 3 quarters · filed 2022-11-02
-$100.00K
derived: sum of 4 quarters · filed 2022-11-02
2021-06-30$274.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-23
$502.00K
derived: sum of 2 quarters · filed 2022-08-23
$939.00K
derived: sum of 3 quarters · filed 2022-08-23
$1.04M
10-K · filed 2022-08-23
2021-03-31$228.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-03
$665.00K
derived: sum of 2 quarters · filed 2022-05-03
$762.00K
10-Q · filed 2022-05-03
-$1.62M
derived: sum of 4 quarters · filed 2022-08-23
2020-12-31$437.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-01
$534.00K
10-Q · filed 2022-02-01
-$1.85M
derived: sum of 3 quarters · filed 2022-08-23
-$473.00K
derived: sum of 4 quarters · filed 2022-08-23
2020-09-30$97.00K
10-Q · filed 2021-11-04
-$2.29M
derived: sum of 2 quarters · filed 2022-08-23
-$910.00K
derived: sum of 3 quarters · filed 2022-08-23
-$1.75M
derived: sum of 4 quarters · filed 2022-08-23
2020-06-30-$2.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-23
-$1.01M
derived: sum of 2 quarters · filed 2022-08-23
-$1.85M
derived: sum of 3 quarters · filed 2022-08-23
-$1.24M
10-K · filed 2022-08-23
2020-03-31$1.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-29
$533.00K
derived: sum of 2 quarters · filed 2021-04-29
$1.15M
10-Q · filed 2021-04-29
-$335.00K
derived: sum of 4 quarters · filed 2021-08-19
2019-12-31-$844.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-02
-$230.00K
10-Q · filed 2021-02-02
-$1.71M
derived: sum of 3 quarters · filed 2021-08-19
-$1.86M
derived: sum of 4 quarters · filed 2021-08-19
2019-09-30$614.00K
10-Q · filed 2020-11-03
-$868.00K
derived: sum of 2 quarters · filed 2021-08-19
-$1.02M
derived: sum of 3 quarters · filed 2021-08-19
$490.00K
derived: sum of 4 quarters · filed 2021-08-19
2019-06-30-$1.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-19
-$1.63M
derived: sum of 2 quarters · filed 2021-08-19
-$124.00K
derived: sum of 3 quarters · filed 2021-08-19
$785.00K
10-K · filed 2021-08-19
2019-03-31-$148.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-05
$1.36M
derived: sum of 2 quarters · filed 2020-05-05
$2.27M
10-Q · filed 2020-05-05
$2.44M
derived: sum of 4 quarters · filed 2020-08-18
2018-12-31$1.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-28
$2.42M
10-Q · filed 2020-01-28
$2.59M
derived: sum of 3 quarters · filed 2020-08-18
$2.78M
derived: sum of 4 quarters · filed 2020-08-18
2018-09-30$909.00K
10-Q · filed 2019-10-30
$1.08M
derived: sum of 2 quarters · filed 2020-08-18
$1.27M
derived: sum of 3 quarters · filed 2020-08-18
$888.00K
derived: sum of 4 quarters · filed 2020-08-18
2018-06-30$171.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-18
$365.00K
derived: sum of 2 quarters · filed 2020-08-18
-$21.00K
derived: sum of 3 quarters · filed 2020-08-18
-$462.00K
10-K · filed 2020-08-18
2018-03-31$194.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-01
-$192.00K
derived: sum of 2 quarters · filed 2019-05-01
-$633.00K
10-Q · filed 2019-05-01
-$2.35M
derived: sum of 4 quarters · filed 2019-08-14
2017-12-31-$386.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-04
-$827.00K
10-Q · filed 2019-02-04
-$2.55M
derived: sum of 3 quarters · filed 2019-08-14
-$818.00K
derived: sum of 4 quarters · filed 2019-08-14
2017-09-30-$441.00K
10-Q · filed 2018-11-01
-$2.16M
derived: sum of 2 quarters · filed 2019-08-14
-$432.00K
derived: sum of 3 quarters · filed 2019-08-14
$338.00K
derived: sum of 4 quarters · filed 2019-08-14
2017-06-30-$1.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-14
$9.00K
derived: sum of 2 quarters · filed 2019-08-14
$779.00K
derived: sum of 3 quarters · filed 2019-08-14
$912.00K
10-K · filed 2019-08-14
2017-03-31$1.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09
$2.50M
derived: sum of 2 quarters · filed 2018-05-09
$2.63M
10-Q · filed 2018-05-09
2016-12-31$770.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-07
$903.00K
10-Q · filed 2018-02-07
2016-09-30$133.00K
10-Q · filed 2017-11-08
2016-06-30-$2.18M
10-K · filed 2018-08-15
2015-06-30-$2.50M
10-K · filed 2017-09-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41